Serina Therapeutics, Inc.(SER) - 2025 Q1 - Quarterly Report

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 Serina Therapeutics, Inc. (Exact name of registrant as specified in its charter) Delaware 82-1436829 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 601 Genome Way, Suite 2001 Huntsville, Alabama 35806 (Address of principal ...